Literature DB >> 11994557

Polyethylene glycol diisocyanate decreases platelet deposition after balloon injury of rabbit femoral arteries.

J E B Burchenal1, Christopher R Deible, Timothy E Deglau, Alan J Russell, Eric J Beckman, William R Wagner.   

Abstract

BACKGROUND: Platelet deposition after angioplasty remains problematic and may contribute to intimal hyperplasia and restenosis. We proposed that polyethylene glycol diisocyanate (PEG-DISO), a polymer that rapidly forms covalent linkages with amine residues on proteins, could mask thrombogenic vascular wall proteins from platelets, thereby abrogating acute platelet deposition. METHODS AND
RESULTS: To test this hypothesis, we isolated the femoral arteries of 10 New Zealand White rabbits and injured them with 3 passes of a 2F Fogarty catheter which was inserted through a distal arteriotomy. Immediately after balloon injury, (111)indium-labeled autologous platelets were infused peripherally and the injured femoral arteries were randomly treated for 1 minute with a PEG-DISO solution in one artery and a control solution of the phosphate buffered saline vehicle in the contralateral artery. Following treatment, reflow was initiated. The vessels were harvested after 1 hour and radioactivity was quantified in a gamma counter. Platelet counts were standardized by weight and expressed as platelets/mg (mean +/- SEM). Platelet deposition onto arteries treated with PEG-DISO was (1.2 +/- 0.5) x 10(6) platelets/mg compared to (5.6 +/- 4.2) x 10(6) platelets/mg onto the contralateral control arteries treated with vehicle (P < 0.005). Scanning electron micrographs of the injured vessel segment confirmed qualitatively less platelet deposition on the treated segments than on the control segments.
CONCLUSION: Treatment with PEG-DISO significantly inhibited platelet deposition after vascular injury. These data support the hypothesis that treatment with PEG-DISO masks surface adhesive proteins from platelet receptors in vivo and that the resulting molecular barrier significantly reduces platelet deposition onto the damaged vessel wall for at least one hour. The formation of a molecularly thin barrier to platelet deposition may thus be a novel and effective treatment to abrogate acute intravascular thrombosis and may have value in the treatment of restenosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994557      PMCID: PMC3167230          DOI: 10.1023/a:1015364024487

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  15 in total

1.  Initial platelet deposition at the human microvascular anastomosis: effect on downstream platelet deposition to intact and injured vessels.

Authors:  P C Johnson; R A Sheppeck; T Macpherson; K O Garrett; J Janosky; M L Bentz
Journal:  Plast Reconstr Surg       Date:  1992-10       Impact factor: 4.730

Review 2.  Role of platelets in restenosis after percutaneous coronary revascularization.

Authors:  H Le Breton; E F Plow; E J Topol
Journal:  J Am Coll Cardiol       Date:  1996-12       Impact factor: 24.094

3.  Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing.

Authors:  J L West; J A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

4.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.

Authors:  P W Serruys; P de Jaegere; F Kiemeneij; C Macaya; W Rutsch; G Heyndrickx; H Emanuelsson; J Marco; V Legrand; P Materne
Journal:  N Engl J Med       Date:  1994-08-25       Impact factor: 91.245

5.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.

Authors:  D L Fischman; M B Leon; D S Baim; R A Schatz; M P Savage; I Penn; K Detre; L Veltri; D Ricci; M Nobuyoshi
Journal:  N Engl J Med       Date:  1994-08-25       Impact factor: 91.245

6.  Molecular barriers to biomaterial thrombosis by modification of surface proteins with polyethylene glycol.

Authors:  C R Deible; P Petrosko; P C Johnson; E J Beckman; A J Russell; W R Wagner
Journal:  Biomaterials       Date:  1998-10       Impact factor: 12.479

7.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.

Authors: 
Journal:  N Engl J Med       Date:  1994-04-07       Impact factor: 91.245

Review 8.  Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.

Authors:  L A Harker
Journal:  Am J Cardiol       Date:  1987-07-31       Impact factor: 2.778

9.  Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators.

Authors:  E J Topol; R M Califf; H F Weisman; S G Ellis; J E Tcheng; S Worley; R Ivanhoe; B S George; D Fintel; M Weston
Journal:  Lancet       Date:  1994-04-09       Impact factor: 79.321

10.  Platelet accumulation in experimental angioplasty: time course and relation to vascular injury.

Authors:  J R Wilentz; T A Sanborn; C C Haudenschild; C R Valeri; T J Ryan; D P Faxon
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

View more
  8 in total

1.  In vivo PEG modification of vascular surfaces for targeted delivery.

Authors:  Timothy E Deglau; Timothy M Maul; Flordeliza S Villanueva; William R Wagner
Journal:  J Vasc Surg       Date:  2011-12-09       Impact factor: 4.268

2.  Targeting microspheres and cells to polyethylene glycol-modified biological surfaces.

Authors:  Timothy E Deglau; Jermaine D Johnson; Flordeliza S Villanueva; William R Wagner
Journal:  J Biomed Mater Res A       Date:  2007-06-01       Impact factor: 4.396

3.  Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles.

Authors:  J M Koziara; J J Oh; W S Akers; S P Ferraris; R J Mumper
Journal:  Pharm Res       Date:  2005-08-26       Impact factor: 4.200

4.  Characterizing the modification of surface proteins with poly(ethylene glycol) to interrupt platelet adhesion.

Authors:  Haiyan Xu; Joel L Kaar; Alan J Russell; William R Wagner
Journal:  Biomaterials       Date:  2006-02-02       Impact factor: 12.479

5.  Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.

Authors:  Omid C Farokhzad; Jianjun Cheng; Benjamin A Teply; Ines Sherifi; Sangyong Jon; Philip W Kantoff; Jerome P Richie; Robert Langer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-10       Impact factor: 11.205

6.  Click hybridization of immune cells and polyamidoamine dendrimers.

Authors:  Leyuan Xu; Olga Yu Zolotarskaya; W Andrew Yeudall; Hu Yang
Journal:  Adv Healthc Mater       Date:  2014-02-13       Impact factor: 9.933

7.  Facile coupling of synthetic peptides and peptide-polymer conjugates to cartilage via transglutaminase enzyme.

Authors:  Marsha Elizabeth Ritter Jones; Phillip B Messersmith
Journal:  Biomaterials       Date:  2007-09-17       Impact factor: 12.479

8.  Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery.

Authors:  Christopher A Holden; Quan Yuan; W Andrew Yeudall; Deborah A Lebman; Hu Yang
Journal:  Int J Nanomedicine       Date:  2010-02-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.